应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
IKT Inhibikase Therapeutics, Inc.
耶稣受难日休市 03-28 16:00:00 EDT
2.16
-0.14
-6.09%
盘后
2.10
-0.06
-2.78%
19:43 EDT
最高
2.44
最低
2.08
成交量
9.79万
今开
2.18
昨收
2.30
日振幅
15.86%
总市值
1,336万
流通市值
1,141万
总股本
618.63万
成交额
21.69万
换手率
1.85%
流通股本
528.31万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Inhibikase Therapeutics Inc 预计每股亏损85美分 - 财报前瞻
Reuters · 03-27 20:35
Inhibikase Therapeutics Inc 预计每股亏损85美分 - 财报前瞻
Inhibikase Therapeutics, Inc.盘中异动 早盘急速下跌6.47%
自选股智能写手 · 03-19
Inhibikase Therapeutics, Inc.盘中异动 早盘急速下跌6.47%
Inhibikase Therapeutics, Inc.盘中异动 大幅跳水5.38%报2.11美元
自选股智能写手 · 03-14
Inhibikase Therapeutics, Inc.盘中异动 大幅跳水5.38%报2.11美元
Inhibikase Therapeutics, Inc.盘中异动 早盘股价大涨6.54%报2.40美元
自选股智能写手 · 03-06
Inhibikase Therapeutics, Inc.盘中异动 早盘股价大涨6.54%报2.40美元
加载更多
公司概况
公司名称:
Inhibikase Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Inhibikase Therapeutics, Inc.于2010年6月3日注册为特拉华州公司。该公司是一家临床阶段制药公司,致力于开发针对帕金森氏病或PD以及大脑内外发生的相关疾病的疗法。
发行价格:
--
{"stockData":{"symbol":"IKT","market":"US","secType":"STK","nameCN":"Inhibikase Therapeutics, Inc.","latestPrice":2.16,"timestamp":1711656000000,"preClose":2.3,"halted":0,"volume":97891,"hourTrading":{"tag":"盘后","latestPrice":2.1,"preClose":2.16,"latestTime":"19:43 EDT","volume":645,"amount":1358.95,"timestamp":1711669397908},"delay":0,"floatShares":5283117,"shares":6186280,"eps":-3.960689,"marketStatus":"耶稣受难日休市","marketStatusCode":7,"change":-0.14,"latestTime":"03-28 16:00:00 EDT","open":2.18,"high":2.4448,"low":2.08,"amount":216868.86672470003,"amplitude":0.158609,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.960689,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1711958400000},"adr":0,"listingDate":1608699600000,"adjPreClose":2.3,"postHourTrading":{"tag":"盘后","latestPrice":2.1,"preClose":2.16,"latestTime":"19:43 EDT","volume":645,"amount":1358.95,"timestamp":1711669397908},"volumeRatio":3.067683},"requestUrl":"/m/hq/s/IKT","defaultTab":"news","newsList":[{"id":"2422995746","title":"Inhibikase Therapeutics Inc 预计每股亏损85美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2422995746","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2422995746?lang=zh_cn&edition=full","pubTime":"2024-03-27 20:35","pubTimestamp":1711542909,"startTime":"0","endTime":"0","summary":" * Inhibikase Therapeutics Inc 预计将在3月29日公布截至2023年12月31日的业绩(),季度收入将出现下降。* * LSEG的分析师平均预计Inhibikase Therapeutics Inc每股亏损85美分。* 华尔街对 Inhibikase Therapeutics Inc 的 12 个月目标价中位数为 17.50 美元,高于其最新收盘价 2.29 美元。3月27日 - 本摘要于北京时间 3 月 27 日 12:35 机器生成。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2420220426","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘急速下跌6.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420220426","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420220426?lang=zh_cn&edition=full","pubTime":"2024-03-19 22:02","pubTimestamp":1710856943,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日22时02分,Inhibikase Therapeutics, Inc.股票出现异动,股价大幅下挫6.47%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.12%。其相关个股中,Fusion Pharmaceuticals Inc.、Hoth Therapeutics, Inc.、Enveric Biosciences, Inc.涨幅较大,Enveric Biosciences, Inc.、Hoth Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃,换手率分别为713.83%、320.66%、131.32%,振幅较大的相关个股有Enveric Biosciences, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Hoth Therapeutics, Inc.,振幅分别为44.55%、30.00%、27.83%。Inhibikase Therapeutics, Inc.公司简介:Inhibikase Therapeutics Inc 是一家临床阶段的制药公司,致力于开发治疗帕金森病和相关疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403192202237a4db57c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403192202237a4db57c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419985449","title":"Inhibikase Therapeutics, Inc.盘中异动 大幅跳水5.38%报2.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419985449","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419985449?lang=zh_cn&edition=full","pubTime":"2024-03-14 23:00","pubTimestamp":1710428424,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日23时00分,Inhibikase Therapeutics, Inc.股票出现异动,股价大幅跳水5.38%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.56%。其相关个股中,Revolution Medicines Inc C/Wts 17/12/2026 、知临集团、Agex Therapeutics, Inc.涨幅较大,知临集团、Novabay Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃,换手率分别为572.84%、161.02%、74.56%,振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、知临集团、Nuvectis Pharma, Inc.,振幅分别为101.40%、76.91%、46.47%。Inhibikase Therapeutics, Inc.公司简介:Inhibikase Therapeutics Inc 是一家临床阶段的制药公司,致力于开发治疗帕金森病和相关疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314230024861de458&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314230024861de458&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417854441","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘股价大涨6.54%报2.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417854441","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417854441?lang=zh_cn&edition=full","pubTime":"2024-03-06 00:25","pubTimestamp":1709655946,"startTime":"0","endTime":"0","summary":"北京时间2024年03月06日00时25分,Inhibikase Therapeutics, Inc.股票出现异动,股价急速拉升6.54%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.38%。其相关个股中,Cingulate Inc C/Wts 10/12/2026 、Ocean Biomedical Inc C/Wts 14/02/2028 、Apogee Therapeutics, Inc.涨幅较大,Quoin Pharmaceuticals Ltd、Jaguar Health, Inc.、Ocean Biomedical, Inc.较为活跃,换手率分别为282.48%、175.47%、102.97%,振幅较大的相关个股有Ys Biopharma Co Ltd C/Wts 15/03/2028 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Nkgen Biotech Inc C/Wts 31/05/2028,振幅分别为70.24%、68.86%、67.57%。Inhibikase Therapeutics, Inc.公司简介:Inhibikase Therapeutics Inc 是一家临床阶段的制药公司,致力于开发治疗帕金森病和相关疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240306002547791786ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240306002547791786ca&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inhibikase.com","stockEarnings":[{"period":"1week","weight":-0.0226},{"period":"1month","weight":-0.0442},{"period":"3month","weight":0.7008},{"period":"6month","weight":0.554},{"period":"1year","weight":-0.4857},{"period":"ytd","weight":0.7008}],"compareEarnings":[{"period":"1week","weight":0.0017},{"period":"1month","weight":0.0318},{"period":"3month","weight":0.1005},{"period":"6month","weight":0.2236},{"period":"1year","weight":0.3033},{"period":"ytd","weight":0.1005}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Inhibikase Therapeutics, Inc.于2010年6月3日注册为特拉华州公司。该公司是一家临床阶段制药公司,致力于开发针对帕金森氏病或PD以及大脑内外发生的相关疾病的疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.425952},{"month":2,"riseRate":0.5,"avgChangeRate":-0.118451},{"month":3,"riseRate":0.25,"avgChangeRate":0.045803},{"month":4,"riseRate":0,"avgChangeRate":-0.183432},{"month":5,"riseRate":0.666667,"avgChangeRate":0.034039},{"month":6,"riseRate":0,"avgChangeRate":-0.263748},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.115578},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.009751},{"month":9,"riseRate":0,"avgChangeRate":-0.186153},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.155622},{"month":11,"riseRate":0.666667,"avgChangeRate":-0.050918},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.028053}],"exchange":"NASDAQ","name":"Inhibikase Therapeutics, Inc.","nameEN":"Inhibikase Therapeutics, Inc."},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.3","shortVersion":"4.22.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inhibikase Therapeutics, Inc.(IKT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Inhibikase Therapeutics, Inc.(IKT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Inhibikase Therapeutics, Inc.,IKT,Inhibikase Therapeutics, Inc.股票,Inhibikase Therapeutics, Inc.股票老虎,Inhibikase Therapeutics, Inc.股票老虎国际,Inhibikase Therapeutics, Inc.行情,Inhibikase Therapeutics, Inc.股票行情,Inhibikase Therapeutics, Inc.股价,Inhibikase Therapeutics, Inc.股市,Inhibikase Therapeutics, Inc.股票价格,Inhibikase Therapeutics, Inc.股票交易,Inhibikase Therapeutics, Inc.股票购买,Inhibikase Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inhibikase Therapeutics, Inc.(IKT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Inhibikase Therapeutics, Inc.(IKT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}